Douglas Yee
Douglas Yee
Professor of Medicine
Verified email at umn.edu
Title
Cited by
Cited by
Year
Diabetes and cancer: a consensus report
E Giovannucci, DM Harlan, MC Archer, RM Bergenstal, SM Gapstur, ...
CA: a cancer journal for clinicians 60 (4), 207-221, 2010
25392010
APOBEC3B is an enzymatic source of mutation in breast cancer
MB Burns, L Lackey, MA Carpenter, A Rathore, AM Land, B Leonard, ...
Nature 494 (7437), 366-370, 2013
6522013
Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins
M Guix, AC Faber, SE Wang, MG Olivares, Y Song, S Qu, C Rinehart, ...
The Journal of clinical investigation 118 (7), 2609-2619, 2008
5822008
Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth
K Gupta, S Kshirsagar, L Chang, R Schwartz, PY Law, D Yee, RP Hebbel
Cancer research 62 (15), 4491-4498, 2002
5552002
Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer
D Yee, S Paik, GS Lebovic, RR Marcus, RE Favoni, KJ Cullen, ...
Molecular Endocrinology 3 (3), 509-517, 1989
4861989
Randomized controlled trial of weight training and lymphedema in breast cancer survivors
RL Ahmed, W Thomas, D Yee, KH Schmitz
Journal of Clinical Oncology 24 (18), 2765-2772, 2006
4082006
Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expression in Vitro and in Vivo
AV Lee, JG Jackson, JL Gooch, SG Hilsenbeck, E Coronado-Heinsohn, ...
Molecular endocrinology 13 (5), 787-796, 1999
4041999
Insulin-like growth factor receptor expression and function in human breast cancer
KJ Cullen, D Yee, WS Sly, J Perdue, B Hampton, ME Lippman, N Rosen
Cancer research 50 (1), 48-53, 1990
4041990
Disrupting insulin-like growth factor signaling as a potential cancer therapy
D Sachdev, D Yee
Molecular cancer therapeutics 6 (1), 1-12, 2007
4022007
The IGF system and breast cancer.
D Sachdev, D Yee
Endocrine-related cancer 8 (3), 197-209, 2001
3992001
Adaptive randomization of veliparib–carboplatin treatment in breast cancer
HS Rugo, OI Olopade, A DeMichele, C Yau, LJ van’t Veer, MB Buxton, ...
New England Journal of Medicine 375 (1), 23-34, 2016
3822016
Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo 1H MR Spectroscopy—A Pilot Study at 4 T1
S Meisamy, PJ Bolan, EH Baker, RL Bliss, E Gulbahce, LI Everson, ...
Radiology 233 (2), 424-431, 2004
3822004
Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells
S Avdulov, S Li, V Michalek, D Burrichter, M Peterson, DM Perlman, ...
Cancer cell 5 (6), 553-563, 2004
3752004
Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins
KH Schmitz, RL Ahmed, PJ Hannan, D Yee
Cancer Epidemiology and Prevention Biomarkers 14 (7), 1672-1680, 2005
3532005
In vivo quantification of choline compounds in the breast with 1H MR spectroscopy
PJ Bolan, S Meisamy, EH Baker, J Lin, T Emory, M Nelson, LI Everson, ...
Magnetic Resonance in Medicine: An Official Journal of the International …, 2003
3082003
Insulin-like growth factor II mRNA expression in human breast cancer
D Yee, KJ Cullen, S Paik, JF Perdue, B Hampton, A Schwartz, ...
Cancer Research 48 (23), 6691-6696, 1988
2871988
Crosstalk between the insulin-like growth factors and estrogens in breast cancer
D Yee, AV Lee
Journal of mammary gland biology and neoplasia 5 (1), 107-115, 2000
2722000
Effects of weight training on quality of life in recent breast cancer survivors: the Weight Training for Breast Cancer Survivors (WTBS) study
T Ohira, KH Schmitz, RL Ahmed, D Yee
Cancer: Interdisciplinary International Journal of the American Cancer …, 2006
2652006
A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I
D Sachdev, SL Li, JS Hartell, Y Fujita-Yamaguchi, JS Miller, D Yee
Cancer research 63 (3), 627-635, 2003
2432003
Adaptive randomization of neratinib in early breast cancer
JW Park, MC Liu, D Yee, C Yau, LJ van’t Veer, WF Symmans, M Paoloni, ...
New England Journal of Medicine 375 (1), 11-22, 2016
2412016
The system can't perform the operation now. Try again later.
Articles 1–20